The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cawthon, A. G.
Right arrow Articles by Alexander-Miller, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cawthon, A. G.
Right arrow Articles by Alexander-Miller, M. A.
The Journal of Immunology, 2001, 167: 2577-2584.
Copyright © 2001 by The American Association of Immunologists

Peptide Requirement for CTL Activation Reflects the Sensitivity to CD3 Engagement: Correlation with CD8{alpha}{beta} Versus CD8{alpha}{alpha} Expression1

Andrew G. Cawthon, Haiping Lu and Martha A. Alexander-Miller2

Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC 27157

In our previous studies, CTL that were sensitive to low concentrations of peptide Ag were found to be far superior to those requiring high concentrations of Ag for reducing viral burden when adoptively transferred into SCID mice. Thus it is important that we understand the mechanisms that control the requirement for peptide Ag with the long-term goal of selectively expanding these exquisitely sensitive cells in vivo. Although TCR affinity is one parameter that can affect the CTL sensitivity for Ag, we investigated whether additional mechanisms may also be involved. In studies using a TCR transgenic mouse model, we successfully generated CTL with identical TCR affinity that possess distinctly different activation requirements. Using both peptide Ag and anti-CD3 Ab to activate the CTL lines of high vs low avidity, we found that the variations in activation threshold are the result of differences in the required number of engaged TCR. Additionally, we have observed that the ratio of CD8{alpha}{beta} to CD8{alpha}{alpha} is significantly greater in CTL lines that are more sensitive to TCR engagement, which may contribute to the lower activation threshold of these CTL following CD3 engagement. These studies identify a novel mechanism by which the activation requirements of Ag-specific CTL are determined by demonstrating a direct correlation between the sensitivity to TCR engagement, the expression of levels CD8{alpha}{beta} vs {alpha}{alpha}, and the amount of peptide Ag required to reach the threshold for activation.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
D. Thakral, J. Dobbins, L. Devine, and P. B. Kavathas
Differential Expression of the Human CD8{beta} Splice Variants and Regulation of the M-2 Isoform by Ubiquitination
J. Immunol., June 1, 2008; 180(11): 7431 - 7442.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. J. Kroger, S. Amoah, and M. A. Alexander-Miller
Cutting Edge: Dendritic Cells Prime a High Avidity CTL Response Independent of the Level of Presented Antigen
J. Immunol., May 1, 2008; 180(9): 5784 - 5788.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. R. Jordan, R. H. McMahan, J. Z. Oh, M. R. Pipeling, D. M. Pardoll, R. M. Kedl, J. W. Kappler, and J. E. Slansky
Baculovirus-Infected Insect Cells Expressing Peptide-MHC Complexes Elicit Protective Antitumor Immunity
J. Immunol., January 1, 2008; 180(1): 188 - 197.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
I. M. Belyakov, S. Kozlowski, M. Mage, J. D. Ahlers, L. F. Boyd, D. H. Margulies, and J. A. Berzofsky
Role of {alpha}3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs
Int. Immunol., December 1, 2007; 19(12): 1413 - 1420.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Quigley, X. Huang, and Y. Yang
Extent of Stimulation Controls the Formation of Memory CD8 T Cells
J. Immunol., November 1, 2007; 179(9): 5768 - 5777.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. J. Kroger and M. A. Alexander-Miller
Cutting Edge: CD8+ T Cell Clones Possess the Potential to Differentiate into both High- and Low-Avidity Effector Cells
J. Immunol., July 15, 2007; 179(2): 748 - 751.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. L. Denning, S. Granger, D. Mucida, R. Graddy, G. Leclercq, W. Zhang, K. Honey, J. P. Rasmussen, H. Cheroutre, A. Y. Rudensky, et al.
Mouse TCR{alpha}beta+CD8{alpha}{alpha} Intraepithelial Lymphocytes Express Genes That Down-Regulate Their Antigen Reactivity and Suppress Immune Responses
J. Immunol., April 1, 2007; 178(7): 4230 - 4239.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Devine, D. Thakral, S. Nag, J. Dobbins, M. E. Hodsdon, and P. B. Kavathas
Mapping the Binding Site on CD8beta for MHC Class I Reveals Mutants with Enhanced Binding
J. Immunol., September 15, 2006; 177(6): 3930 - 3938.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Kedzierska, N. L. La Gruta, M. P. Davenport, S. J. Turner, and P. C. Doherty
Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses
PNAS, August 9, 2005; 102(32): 11432 - 11437.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. M. Ercolini, B. H. Ladle, E. A. Manning, L. W. Pfannenstiel, T. D. Armstrong, J.-P. H. Machiels, J. G. Bieler, L. A. Emens, R. T. Reilly, and E. M. Jaffee
Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response
J. Exp. Med., May 16, 2005; 201(10): 1591 - 1602.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Oh, L. P. Perera, D. S. Burke, T. A. Waldmann, and J. A. Berzofsky
IL-15/IL-15R{alpha}-mediated avidity maturation of memory CD8+ T cells
PNAS, October 19, 2004; 101(42): 15154 - 15159.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
L. T. Madakamutil, U. Christen, C. J. Lena, Y. Wang-Zhu, A. Attinger, M. Sundarrajan, W. Ellmeier, M. G. von Herrath, P. Jensen, D. R. Littman, et al.
CD8{alpha}{alpha}-Mediated Survival and Differentiation of CD8 Memory T Cell Precursors
Science, April 23, 2004; 304(5670): 590 - 593.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Oh, J. W. Hodge, J. D. Ahlers, D. S. Burke, J. Schlom, and J. A. Berzofsky
Selective Induction of High Avidity CTL by Altering the Balance of Signals from APC
J. Immunol., March 1, 2003; 170(5): 2523 - 2530.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. N. J. Bullock, D. W. Mullins, and V. H. Engelhard
Antigen Density Presented By Dendritic Cells In Vivo Differentially Affects the Number and Avidity of Primary, Memory, and Recall CD8+ T Cells
J. Immunol., February 15, 2003; 170(4): 1822 - 1829.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. G. Cawthon and M. A. Alexander-Miller
Optimal Colocalization of TCR and CD8 as a Novel Mechanism for the Control of Functional Avidity
J. Immunol., October 1, 2002; 169(7): 3492 - 3498.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. M. Gray, G. D. Parks, and M. A. Alexander-Miller
A Novel CD8-Independent High-Avidity Cytotoxic T-Lymphocyte Response Directed against an Epitope in the Phosphoprotein of the Paramyxovirus Simian Virus 5
J. Virol., November 1, 2001; 75(21): 10065 - 10072.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.